<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04037813</url>
  </required_header>
  <id_info>
    <org_study_id>140689</org_study_id>
    <nct_id>NCT04037813</nct_id>
  </id_info>
  <brief_title>Hysteroscopic Versus Laparoscopic Tubal Occlusion in Cases of Hydrosalpinx and Planning for IVF</brief_title>
  <official_title>Comparative Study of Hysteroscopic Versus Laparoscopic Tubal Occlusion in Cases of Communicating Hydrosalpinx and Planning for IVF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      compare the efficacy of hysteroscopic tubal occlusion versus laparoscopic tubal occlusion for&#xD;
      the patients of communicating hydrosalpinx scheduled for IVF. half of the patients will&#xD;
      undergo hysteroscopic tubal occlusion while the other half will undergo laparoscopic tubal&#xD;
      occlusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include 108 patients complaining of infertility associated with unilateral or&#xD;
      bilateral tubal communicating hydrosalpinx. All the patients will be subjected to informed&#xD;
      consent, history taking, full physical examination, ultrasound examination via transvaginal&#xD;
      approach using ultrasound machine ( Voluson Pro-V and GE Voluson E 10) and HSG within the&#xD;
      last 6 months showing unilateral or bilateral communicating hydrosalpinx.&#xD;
&#xD;
      The patients (108) will be equally randomized into two groups :&#xD;
&#xD;
      Group (A): 54 patients (Hysteroscopic tubal occlusion group). Group (B): 54 patients&#xD;
      (Laparoscopic tubal occlusion group). Randomization will be done using 108 opaque sealed&#xD;
      envelopes that will be numbered serially from 1-108 and each envelope corresponding letter&#xD;
      which denotes the allocated group will be put according to randomization table then all&#xD;
      envelopes will be closed and put in one box, when the first patient arrives, after giving&#xD;
      informed consent, the first envelope will be opened and the patient will be allocated&#xD;
      according to the letter inside.&#xD;
&#xD;
      For hysteroscopic tubal occlusion group it will be done under general anesthesia using&#xD;
      standard, rigid 4-mm hysteroscopy with a 30° forward-oblique lens and a 5.5-mm diagnostic&#xD;
      sheath (Karl Storz , Germany). Uterine distension allowed a panoramic view of the uterine&#xD;
      cavity and identification of the tubal ostia.The roller ball (Ball Electrode, unipolar, 5 Fr)&#xD;
      will be used for the coagulation of the interstitial part of the tube and the uterine cornu&#xD;
      area.&#xD;
&#xD;
      For laparoscopic tubal occlusion group it will be done under general anesthesia using bipolar&#xD;
      coagulation and a proximal tubal cut. The contraindications for laparoscopy were mainly&#xD;
      extensive abdominal or pelvic adhesions of various etiologies (e.g. previous surgery, pelvic&#xD;
      inflammatory disease, and pelvic endometriosis) and morbid obesity.&#xD;
&#xD;
      The operative details of hysteroscopic tubal occlusion and laparoscopic tubal occlusion&#xD;
      including operative time and complications will be documented In both groups, the patients&#xD;
      will be followed up for the next 24 hours as regard post-operative pain (using VAS ) and&#xD;
      post-operative recovery (patient mobilization, intestinal motility and patient discharge).&#xD;
&#xD;
      The success rate of tubal occlusion will be assessed one month later using post-menstrual HSG&#xD;
      and for hysteroscopic group office hysteroscopy will be done for assessment of uterine cavity&#xD;
      after electrocoagulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2019</start_date>
  <completion_date type="Actual">September 15, 2020</completion_date>
  <primary_completion_date type="Actual">August 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients with successful hysteroscopic tubal occlusion</measure>
    <time_frame>one month post-operative.</time_frame>
    <description>Successful tubal occlusion will be measured by the presence of negative spill and proximal tubal block on HSG.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The percentage of patients with successful laparoscopic tubal occlusion</measure>
    <time_frame>one month post-operative.</time_frame>
    <description>Successful tubal occlusion will be measured by the presence of negative spill and proximal tubal block on HSG.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The post-operative pain in both groups (using VAS ).</measure>
    <time_frame>24 hours post-operative.</time_frame>
    <description>The patients will be followed up for the next 24 hours as regard post-operative pain (using VAS) .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The operative time and complications in both groups.</measure>
    <time_frame>Intra-operative duration.</time_frame>
    <description>the operative time and operative complications will be documented according to the hospital records .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the success rate of tubal occlusion in both groups.</measure>
    <time_frame>one month post-operative.</time_frame>
    <description>The number of HSG that showed post-operative tubal occlusion in hysteroscopic group compared to laparoscopic group.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">108</enrollment>
  <condition>Tubal Obstruction</condition>
  <arm_group>
    <arm_group_label>Laparoscopic tubal occlusion</arm_group_label>
    <description>54 patients will undergo laparoscopic tubal occlusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysteroscopic tubal occlusion</arm_group_label>
    <description>54 patients will undergo hysteroscopic tubal occlusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic and hysteroscopic tubal occlusion for hydrosalpinx</intervention_name>
    <description>For hysteroscopic tubal occlusion group it will be done under general anesthesia using standard, rigid 4-mm hysteroscopy with a 30° forward-oblique lens and a 5.5-mm diagnostic sheath (Karl Storz , Germany). Uterine distension allowed a panoramic view of the uterine cavity and identification of the tubal ostia.The roller ball (Ball Electrode, unipolar, 5 Fr) will be used for the coagulation of the interstitial part of the tube and the uterine cornu area.&#xD;
For laparoscopic tubal occlusion group it will be done under general anesthesia using bipolar coagulation and a proximal tubal cut.</description>
    <arm_group_label>Hysteroscopic tubal occlusion</arm_group_label>
    <arm_group_label>Laparoscopic tubal occlusion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        108 patients complaining of infertility associated with unilateral or bilateral tubal&#xD;
        hydrosalpinx and planning for IVF, all the patients will be recruited from the outpatient&#xD;
        clinic at Kasr El Eini teaching hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary or secondary infertility.&#xD;
&#xD;
          -  The presence of communicating hydrosalpinx diagnosed by HSG,TV U/S showing distended&#xD;
             tubes and intrauterine fluid or patient complaining of prolonged brownish vaginal&#xD;
             discharge.&#xD;
&#xD;
          -  Candidate for IVF procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uterine anomalies.&#xD;
&#xD;
          -  Serious medical condition and unfit for surgery.&#xD;
&#xD;
          -  Contraindication for laparoscopic tubal occlusion.&#xD;
&#xD;
          -  Contraindication for pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud A Abdelsalam, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>22222</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 21, 2019</study_first_submitted>
  <study_first_submitted_qc>July 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>April 18, 2021</last_update_submitted>
  <last_update_submitted_qc>April 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mahmoud Ahmed Abdel Salam</investigator_full_name>
    <investigator_title>Assistant lecturer in obstetrics and gynecology department</investigator_title>
  </responsible_party>
  <keyword>Hysteroscopy</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Hydrosalpinx</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fallopian Tube Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

